Top Markets
Coin of the day
Sartorius Aktiengesellschaft Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

SOAGY
Classificação em ações #317
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and... Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products. In addition, the company offers process filtration products; process filtration products; process chromatography products; fluid management products; process analytical technology and data analytics; industrial microbiology systems; water purification systems; weighing systems; pipetting and dispensing systems; OEM systems; and centrifuges. Further, it provides bioprocess development and engineering, protein expression system, media and process, testing, instrument, and validation services. It serves the life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.
Preço da ação
$47.54
Valor de mercado
$69.46B
Variação (1 dia)
-3.59%
Variação (1 ano)
-9.07%
País
DE
Negociar Sartorius Aktiengesellschaft (SOAGY)

Categoria

Rácio P/E de Sartorius Aktiengesellschaft (SOAGY)
Rácio P/E em March 2026 TTM: 107.05
De acordo com os últimos relatórios financeiros e o preço das ações da Sartorius Aktiengesellschaft, o rácio P/E atual (TTM) é 107.05. No final de 2023, a empresa tinha um P/E de 115.13.
Histórico do rácio P/E da Sartorius Aktiengesellschaft de 2002 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
2026 (TTM) 107.05 -39.42%
2024 176.71 53.49%
2023 115.13 315.95%
2022 27.68 -70.98%
2021 95.37 30.42%
2020 73.13 22.59%
2019 59.65 12.80%
2018 52.88 10.69%
2017 47.78 2.00%
2016 46.84 44.32%
2015 32.46 -8.75%
2014 35.57 26.42%
2013 28.13 16.57%
2012 24.14 110.44%
2011 11.47 -23.94%
2010 15.08 -94.58%
2009 278.35 3,158.24%
2008 8.54 -43.48%
2007 15.12 -20.87%
2006 19.10 20.76%
2005 15.82 -7.24%
2004 17.05 -33.05%
2003 25.47 79.68%
2002 14.18 0.00%
Rácio P/E para empresas semelhantes ou concorrentes
Empresa Rácio P/E Diferença do rácio P/E País
62.57 -41.55%
US
28.63 -73.25%
US
38.22 -64.30%
JP
43.53 -59.34%
CH
25.26 -76.40%
US
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.